Showing results (661-670 of 3,470) with videos related to

Sort By:
Pageof 347
Clinical Pharmacokinetics|May 2, 2026
Evaluating Bayesian Vancomycin Dosage Adjustment in Neonates: A Simulation-Based Virtual TDM StudyAnne Ravix, Yann Thoma, Annie Cathignol, et al.
Clinical Pharmacokinetics|May 1, 2026
Impacts of Uremic Toxins on the Population Pharmacokinetics of Total Mycophenolic Acid and its Glucuronide Metabolite in Adult Kidney Transplant RecipientsAla'a R Al-Dajani, Yan Rong, Jinal Adhiya, et al.
Clinical Pharmacokinetics|April 8, 2026
Why the Assay Matters in Model-Informed Precision Dosing: An Example of Ustekinumab in Crohn's DiseaseWei Zhang, Zhigang Wang, Thierry Dervieux, et al.
Clinical Pharmacokinetics|April 29, 2026
Population Pharmacokinetics of Sacubitril/Valsartan in Patients with Heart Failure and End-Stage Renal Disease Undergoing Peritoneal DialysisYing Jin, Nuo Xu, Wenyu Yang, et al.
Clinical Pharmacokinetics|March 12, 2026
Population Pharmacokinetic Modeling of Encorafenib in Healthy Participants and Patients with BRAF V600-Mutant Solid Tumors: A Semi-mechanistic Autoinduction ModelDerek Z Yang, Erik M Hahn, Joseph Piscitelli, et al.
Clinical Pharmacokinetics|February 14, 2026
Utilization of Apixaban Pharmacokinetics for Dose Optimization in High-Risk Elderly PatientsRachel Goldstein, Khaled Sandouka, Lana Zighan, et al.
Clinical Pharmacokinetics|August 5, 2009
Systemic exposure and implications for lung deposition with an extra-fine hydrofluoroalkane beclometasone dipropionate/formoterol fixed combinationJean Bousquet, Gianluigi Poli, Daniela Acerbi, et al.
Clinical Pharmacokinetics|January 8, 2017
Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic DisordersElisabeth I Minder, Jasmin Barman-Aksoezen, Xiaoye Schneider-Yin
Clinical Pharmacokinetics|December 16, 2016
Pharmacokinetics of Deferiprone in Patients with β-Thalassaemia : Impact of Splenectomy and Iron StatusLie Michael George Limenta, Totsapol Jirasomprasert, Piyada Jittangprasert, et al.
Clinical Pharmacokinetics|December 16, 2016
Predictive Performance of a Recently Developed Population Pharmacokinetic Model for Morphine and its Metabolites in New Datasets of (Preterm) Neonates, Infants and ChildrenElke H J Krekels, Joost DeJongh, Richard A van Lingen, et al.
Pageof 347